Regeneron Pharmaceuticals Collaboration revenue
Collaboration revenue at Regeneron Pharmaceuticals came to $3.0B for the quarter to 30 Sep 2026, up 52.4% from a year earlier.
As Regeneron Pharmaceuticals reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 30 Oct 2026.
By quarter
| Period ending | Collaboration revenue | Change on a year | Filed |
|---|---|---|---|
| 30 Sep 2026 | $3.0B | up 52.4% | 30 Oct 2026 |
| 30 Jun 2026 | $2.5B | up 31.9% | 30 Jul 2026 |
| 31 Mar 2026 | $1.9B | up 24.1% | 29 Apr 2026 |
| 31 Dec 2025 | $2.0B | up 22.7% | 4 Feb 2026 |
| 30 Sep 2025 | $2.0B | up 18.6% | 28 Oct 2025 |
| 30 Jun 2025 | $1.9B | up 22.1% | 1 Aug 2025 |
| 31 Mar 2025 | $1.5B | up 20.9% | 29 Apr 2025 |
| 31 Dec 2024 | $1.6B | up 17.3% | 5 Feb 2025 |
| 30 Sep 2024 | $1.7B | up 15.4% | 31 Oct 2024 |
| 30 Jun 2024 | $1.5B | up 15.7% | 1 Aug 2024 |
| 31 Mar 2024 | $1.3B | down 8.1% | 2 May 2024 |
| 31 Dec 2023 | $1.4B | — | 5 Feb 2024 |
| 30 Sep 2023 | $1.4B | up 36.9% | 2 Nov 2023 |
| 30 Jun 2023 | $1.3B | up 26.2% | 3 Aug 2023 |
| 31 Mar 2023 | $1.4B | up 11.8% | 4 May 2023 |
| 30 Sep 2022 | $1.1B | down 2.2% | 3 Nov 2022 |
| 30 Jun 2022 | $1.0B | up 9.3% | 3 Aug 2022 |
| 31 Mar 2022 | $1.2B | up 63.4% | 4 May 2022 |
| 30 Sep 2021 | $1.1B | up 64.4% | 4 Nov 2021 |
| 30 Jun 2021 | $954.7M | up 86.0% | 5 Aug 2021 |
| 31 Mar 2021 | $754.4M | up 42.8% | 6 May 2021 |
| 30 Sep 2020 | $653.2M | — | 5 Nov 2020 |
| 30 Jun 2020 | $513.3M | — | 5 Aug 2020 |
| 31 Mar 2020 | $528.3M | — | 5 May 2020 |
Definition
Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.
Other operating KPIs of Regeneron Pharmaceuticals: Net product sales · Libtayo revenue · Lynozyfic revenue · EYLEA HD And EYLEA revenue · EYLEA HD revenue · EYLEA revenue · Praluent revenue · Evkeeza revenue · financial statements
Every KPI and segment of REGN, in the terminal.
Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.
